Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Simplify Provides Estimated Capital Gain Distribution Information for 2025
Cascades Inc. (TSE:CAS) Receives Consensus Rating of “Moderate Buy” from Brokerages
Cascades Inc. (CAS:CA) Q3 2025 Earnings Call Transcript
Fannie Mae Announces Results of Tender Offer for Any and All of Certain CAS Notes
Fannie Mae Announces Tender Offer for Any and All of Certain CAS Notes
Fannie Mae Announces Results of Tender Offer for Any and All of Certain CAS Notes
Fannie Mae Announces Tender Offer for Any and All of Certain CAS Notes
KBRA Assigns Preliminary Ratings to Fannie Mae's CAS 2025-R03
L3Harris' Commercial Aviation Solutions (CAS) Business, now known as Acron Aviation
KBRA Assigns Preliminary Ratings to Fannie Mae's CAS 2025-R02
Harnessing The Red Dragon: Making China's Equity Market Structure Work For Better Returns
Gold-Rich Cobalt-Copper Mineralization at CAS Property Strengthens Electra's Idaho Exploration Strategy
Fannie Mae Announces 2025 Connecticut Avenue Securities (CAS) Issuance Calendar
Fannie Mae Prices $708 Million Connecticut Avenue Securities (CAS) REMIC Deal
Fannie Mae Prices $659 Million Connecticut Avenue Securities (CAS) REMIC Deal
Fannie Mae Prices $708 Million Connecticut Avenue Securities (CAS) REMIC Deal
KBRA Assigns Preliminary Ratings to Fannie Mae's CAS 2024-R04
KBRA Assigns Preliminary Ratings to Fannie Mae’s CAS 2024-R04
Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in Japan Evaluating TEPEZZA® (teprotumumab-trbw) in Adults with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED)
Cascades Inc. (CADNF) Q3 2022 Earnings Call Transcript